Cart

0

Stocks

“Morgan Stanley Bets on These 3 Stocks; Sees Over 40% Upside”

Akero Therapeutics (AKRO)

Are other analysts in agreement? They are. Only Buy ratings, 6, in fact, have been issued in the last three months. Therefore, the message is clear: AKRO is a Strong Buy. Given the $58.50 average price target, shares could rise 61% in the next year…

TransDigm Group (TDG)

Looking at the consensus breakdown, 7 Buys and 5 Holds have been published in the last three months. Therefore, TDG gets a Moderate Buy consensus rating. Based on the $500.58 average price target, shares are poised to stay range-bound for now…

Cemex SAB (CX)

Turning to the rest of the analyst community, opinions are split almost evenly. 6 Buys and 5 Holds add up to a Moderate Buy consensus rating. At $4.16, the average price target implies 4% upside potential…”

https://finance.yahoo.com/news/morgan-stanley-bets-3-stocks-202534828.html 

Leave a Reply